Author's posts
Why is the world’s first universal coronavirus vaccine not in the FDA’s toolbox?
Success in any project is based on using the right tool for the job. No tool would be more effective in the campaign against COVID than Covaxin, which has shown its value in India and other markets during recent months. While mRNA vaccines were a prom…
Covaxin: Doomed to the dugout or ready to join the field of vaccine options?
With apologies to the late Yankees slugger Yogi Berra, for pandemic-weary Americans, it’s like “déjà vu all over again,” as new lockdowns and mandatory mask mandates are being imposed across the globe. The latest threat, the Omicron C…
The American public deserves more COVID-19 vaccine options
Covaxin, an inactivated SARS-CoV-2 vaccine and the only vaccine to have been proven effective against all variants including the Delta variant in a Phase III clinical study, deserves to be tested in clinical trials in the U.S. for potential CDC/FDA app…
